# Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

> **NCT04060017** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Southwest Autism Research & Resource Center** · enrollment: 80 (estimated)

## Conditions studied

- Autism Spectrum Disorder
- Language Disorders

## Interventions

- **DRUG:** Levoleucovorin Calcium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04060017
- **Lead sponsor:** Southwest Autism Research & Resource Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-22
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04060017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04060017, "Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04060017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*